1. Abstract The coronavirus disease 2019 (COVID-19) vaccine helps to develop immunity to SARS-CoV-2, the virus that causes COVID-19, in most cases preventing the disease. Although various brands of vaccines work in different modes, all COVID-19 vaccines prompt an immune reaction to make the body remembers how to protect from the virus in the future. …
Mixing of Sputnik V and Astrazeneca COVID-19 Vaccines Read More »
1. Abstract 1.1. Background and Objective: Guanine nucleotide binding protein-like 3-like (GNL3L) plays critical roles in development and progression of several types of human cancers. However, the function and clinical significance of GNL3L in colorectal cancer (CRC) remain unclear. In this study, the effect of GNL3L in CRC and its underlying mechanism were investigated. DOI:http://dx.doi.org/10.47829/JJGH.2021.62103
1. Abstract The primary indication for an esophagectomy is esophageal cancer or Barrett’s esophagus with high-grade dysplasia. Patients undergoing esophagectomy often present with dysphagia, side effects from chemotherapy, decreased appetite, and weight loss. Esophagectomy may be an operation involving the abdomen, neck, and/or chest requiring 5 to 7 days of NPO status to permit healing …
1. Abstract 1.1. Introduction: Approximately one third of the world’s population has serological evidence of past or present infection with the hepatitis B virus (HBV). An estimated 350-400 million people are surface HBV antigen (HBsAg) carriers. India has 40 million HBV carriers i.e. 10–15% share of total pool of HBV carriers of the world. In …
Need of Dual Antiviral Treatment in Chronic Hepatitis B Read More »
1. Abstract 1.1. Background: Eosinophil Cationic Protein (ECP) has proven a useful monitor for many active eosinophilic inflammatory diseases. In the last years we have successfully treated patients suffered from eosinophilic esophagitis whit Allergen Specific Immunotherapy (AIT) and diet guided by Component-Resolved Diagnosis (CRD), that could detect possible allergens involved in eosinophilic esophagitis (EoE). DOI:http://dx.doi.org/10.47829/JJGH.2021.61901
1. Abstract 1.1. Introduction: Chronic hepatitis C is one of the most common cause all over the world for causing cirrhosis of liver. It is commonly seen in Chronic Kidney Disease (CKD) patients who are on maintenance dialysis and treatment with oral directly acting antiviral is challenging due to renal side effects of sofosbuvir which …
1. Abstract 1.1. Introduction: Covid-19 is an ongoing global pandemic around the world which has led to devastation both with human lives as well as economy. The agony of patients who get infected with this deadly virus, does not end with recovery from it, as many face Post Covid-19 complications. There is very limited data …
Post Covid-19 Complications After First Wave in Haryana Read More »
1. Introduction Cirrhosis is a fibrosing disease that constitutes the terminal stage of chronic liver pathologies. It is a major public health problem. Indeed, the incidence in the world varies from 1.3 to 5.9. In France, the annual incidence is 150 to 200 cases per million inhabitants [1]. http://dx.doi.org/10.47829/JJGH.2021.61702
1. Abstract 1.1. Introduction: Hepatitis B Virus (HBV) is a major cause of chronic hepatitis, cirrhosis and hepatocellular carcinoma. There are three possible routes of transmission of HBV from infected mothers to infants: transplacental transmission of HBV in uteri, natal transmission during delivery or postnatal transmission during care of infant or through breast milk.
1. Abstract 1.1. Aims: Gastrointestinal Stromal Tumors (GISTs) are the most common mesenchymal tumors, representing 1-3% of all gastrointestinal cancer. Surgical resection is the only curative treatment. Minimally invasive approaches such as laparoscopic and robotic-assisted resections for gastric GISTs have proved to be oncologically and surgically safe. We report here a case series of robot-assisted …
Robotic-Assisted Gastric GIST Resection: A Single Center Experience Read More »
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.